Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2022 Earnings Call Transcript March 23, 2023
Operator: Greetings and welcome to Relmada Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Tim McCarthy. Thank you, you may begin.
Tim McCarthy: Thank you, operator, and thank you all for joining us this afternoon. With me on today’s call are, Chief Executive Officer,...
